| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | General Counsel &Secretary
3 companies
Sullivan Mark is a General Counsel &Secretary at Carisma Therapeutics Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $9.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | DFTX Definium Therapeutics, Inc. | Chief Legal Officer | Sell | 10,702 | $18.47 | $197,665.94 | -3.8% | - | - | |
| Dec 26, 2025 | Chief Legal Officer | Sell | 11,276 | $13.15 | $148,244.44 | -3.8% | - | - | ||
| Sep 25, 2025 | Chief Legal Officer | Sell | 11,278 | $9.77 | $110,186.06 | -3.7% | - | - | ||
| Jun 25, 2025 | Chief Legal Officer | Sell | 11,491 | $6.80 | $78,138.80 | -3.6% | - | - | ||
| Mar 25, 2025 | Chief Legal Officer | Sell | 6,576 | $6.74 | $44,322.24 | -2.0% | - | - | ||
| Dec 26, 2024 | Chief Legal Officer | Sell | 4,519 | $7.43 | $33,576.17 | -2.5% | - | - | ||
| Sep 25, 2024 | Chief Legal Officer | Sell | 4,430 | $5.98 | $26,491.40 | -2.4% | - | - | ||
| Jun 25, 2024 | Chief Legal Officer | Sell | 17,854 | $7.22 | $128,905.88 | -8.9% | - | - | ||
| Mar 2, 2023 | CARM Carisma Therapeutics Inc. | General Counsel &Secretary | Sale+OE | 219,218 | $0.59 | $128,680.97 | -19.8% | - | - | |
| Feb 21, 2023 | CARM Carisma Therapeutics Inc. | General Counsel &Secretary | Sell | 39,831 | $0.59 | $23,392.75 | -11.7% | - | - |